Results 251 to 260 of about 41,337 (280)
Some of the next articles are maybe not open access.

Treatment of MDS/MPN and the MDS/MPN IWG International Trial: ABNL MARRO

Current Hematologic Malignancy Reports, 2019
MDS/MPNs comprise a group of rare hematologic malignancies that balance features of myeloproliferation and bone marrow failure. Given overlapping clinical features and rarity of incidence, MDS/MPNs have long posed a diagnostic and therapeutic challenge.
Andrew T, Kuykendall, Eric, Padron
openaire   +2 more sources

Sexuality Challenges, Intimacy, and MPN Symptom Burden: An Analysis By The MPN Quality Of Life International Study Group (MPN-QOL ISG)

Blood, 2013
Abstract Background We have previously reported on the high prevalence and severity of challenges with intimacy and sexuality amongst a large international cohort of MPN patients (Emanuel JCO 2012). We sought to further analyze the relationships between issues of intimacy (sexual desire and function),
H.L., Geyer   +47 more
openaire   +4 more sources

Myeloproliferative Neoplasm (MPN)

2020
MPNs comprise various groups of clonal hematopoietic stem cell disorders. The WHO classification 2017 subdivides MPNs into BCR-ABL1-positive chronic myeloid leukaemia (CML) and BCR-ABL1-negative or Philadelphia (Ph) chromosome negative MPNs.
Christine Beham-Schmid   +1 more
openaire   +1 more source

Itchy mast cells in MPNs

Blood, 2009
In this issue of Blood, Ishii and colleagues investigate the role of mast cells in the pathogenesis of pruritus in patients with MPNs.
openaire   +2 more sources

MPN-associated myelofibrosis (MPN-MF)

Leukemia Research, 2011
R A, Mesa   +5 more
openaire   +2 more sources

MPN and transplantation

Leukemia Research, 2016
openaire   +2 more sources

Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives

Cells, 2021
Julian Baumeister   +2 more
exaly  

Lessons From Mouse Models of MPN

International Review of Cell and Molecular Biology, 2022
Jean-Luc Villeval   +2 more
exaly  

MPN-531 Direct and Indirect Costs For Patients With Myeloproliferative Neoplasms (MPNs)

Clinical Lymphoma Myeloma and Leukemia, 2023
Jingbo Yu   +5 more
openaire   +1 more source

Home - About - Disclaimer - Privacy